AI-generated from publicly available materials.Switzerland's Aeon has successfully extended its Seed funding and acquired Aware Health, a German blood diagnostics platform, marking a significant milestone in its mission to redefine preventive healthcare.
Aeon, based in Zurich, has now raised over €12 million in total Seed funding, building on its previous €8.2 million round from June 2025. This extension was co-led by Araya Ventures, with contributions from several existing investors. The company aims to transform preventive care by integrating AI with whole-body imaging and blood diagnostics to create predictive health profiles for individuals.
The acquisition of Aware Health is pivotal for Aeon, positioning it as the first European platform to offer a continuous health monitoring solution that combines imaging and blood diagnostics. This innovative approach allows for real-time updates to health records, enabling early detection of health risks through longitudinal data analysis. Aeon plans to leverage Aware's technology and customer base, which includes nearly 10,000 active users, to enhance its service offerings and expand its market presence in Europe, particularly in Germany, where it has seen rapid growth.
As the healthcare landscape increasingly shifts towards preventive measures, Aeon's integration of advanced diagnostics and AI could set a new standard in the industry. The company’s focus on creating a comprehensive health picture for users not only enhances individual health management but also positions Aeon as a leader in the evolving European healthcare market.